Clinical Trial

Latarjet vs Anatomic Glenoid Reconstruction

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
Anterior shoulder dislocations occur when the humeral head translates anterior to the glenoid cause pain, stiffness, and glenoid bone loss. If left untreated, the risk of recurrence can be up to or greater than 90%. The only surgically modifiable factor to reduce the risk of recurrence is the glenoid bone loss (GBL), where surgeons have the ability to recreate the shape of the glenoid and reduce the risk of recurrent shoulder dislocations. Established boney procedures for shoulder instability include the Latarjet and free bone block procedures, such as the Anatomic Glenoid Reconstruction (AGR). The Latarjet is well known for its lower rate of recurrent instability, but raises concerns due to under-appreciated complications rates. The AGR is a newer surgical approach that has garnered attention for its low rate of recurrent instability and complication profile. Both treatments can reduce pain, increase function following surgery and reduce the risk of recurrent instability. However, these two established approaches have yet to be directly compared and studied on a larger scale. The purpose of this randomized control trial is to compare clinical and radiographic outcomes pre- and post-operatively between the Latarjet to the AGR.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-12; most recent amendment 2024-08-20.
Status change: Not Yet Recruiting → Recruiting 2023-04-24
Trial Details
NCT Number NCT05658289
Lead Sponsor Nova Scotia Health Authority
Conditions Shoulder Dislocation, Bone Loss, Arthroscopy
Enrollment 68 participants
Start Date 2023-04-24
Primary Completion 2026-01 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-22